Investigation of high-mobility group box 1 variants with lymph node status and colorectal cancer risk
- PMID: 40235898
- PMCID: PMC11995333
- DOI: 10.4251/wjgo.v17.i4.102584
Investigation of high-mobility group box 1 variants with lymph node status and colorectal cancer risk
Abstract
Background: Accumulating studies indicated that maintain nuclei homeostasis was deemed to the protective factors for the occurrence of cancer. Thus, high-mobility group box 1 (HMGB1) might influence the risk and poorer prognoses of colorectal cancer (CRC).
Aim: This study was designed to investigate whether HMGB1 polymorphisms influence the risk and lymph node metastasis (LNM) of CRC.
Methods: Firstly, we designed an investigation with 1003 CRC patients and 1303 cancer-free controls to observe whether HMGB1 rs1412125 T > C and rs1045411 C > T SNPs could influence the risk of cancer. Subsequently, we carried out a correlation-analysis to assess whether these SNPs could alter the risk of LNM.
Results: The current investigation suggested a relationship of HMGB1 rs1412125 SNP with the increased susceptibility of CRC. In a subgroup analysis, our findings suggested that this SNP could enhance an occurrence of CRC in ≥ 61 years, non-drinker and body mass index < 24 kg/m2 subgroups. However, we found that there was null association between HMGB1 rs1412125 SNP and LNM, even in different CRC region. These observations were confirmed by calculating the power value (more than 0.8). The association of HMGB1 rs1045411 C > T SNP with CRC risk and LNM was not found in any compare.
Conclusion: This study highlights a possible association between HMGB1 rs1412125 polymorphism and the increased risk of CRC. In the future, more studies should be conducted to explore HMGB1 rs1412125 polymorphism in relation to CRC development.
Keywords: Colorectal cancer; High-mobility group box 1; Immune; Lymph nodes metastasis; Polymorphism.
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Figures
References
-
- Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132. - PubMed
-
- Li W, Xiao D, Wu H, Xu L. The epithelial cadherin -160C/A polymorphism is associated with decreased risk of colorectal cancer: a case-control study. Clin Exp Med. 2020;20:73–78. - PubMed
-
- Kassim SA, Yang X, Abbas M, Wu S, Faran Ashraf Baig MM, Meng QT, Zhang C, Li X, Chen R. Pri-miR-34b/c rs4938723 Polymorphism is Associated with Decreased Risk and Better Prognosis for Colorectal Cancer Patients. Arch Med Res. 2019;50:55–62. - PubMed
LinkOut - more resources
Full Text Sources